Temporal release of growth factors from 3D micro rod scaffolds for tissue regeneration
The present invention relates to the use of three-dimensional microrod scaffolds for the temporal release of growth factors useful in tissue regeneration, engineering and treatment of disorders.
1. A scaffold comprising microrods and optionally a carrier, wherein the microrods have a stiffness ranging from about 1 kPa to about 1GPa, and wherein the microrods have a rod shape having dimensions of A×B×L, wherein A is 1-30 μm, B is 1-30 μm, and L is 50-120 μm.
2. The scaffold according to claim 1 wherein the carrier is a matrix.
3. The scaffold according to claim 2 wherein said matrix is selected from the group consisting of collagen, gelatin, gluten, elastin, albumin, chitin, hyaluronic acid, cellulose, dextran, pectin, heparin, agarose, fibrin, alginate, carboxymethylcellulose, a hydrogel formed by a solubilized basement membrane preparation extracted from the Engelbreth-Holm-Swarm (EHS) mouse sarcoma, hydrogel and organogel.
4. The scaffold according to claim 1 wherein said microrods modulate the local microenvironment of a cell.
5. The scaffold according to claim 1 wherein said microrods alter cellular cytoskeletal architecture.
6. The scaffold according to claim 1 wherein said microrods alter cellular proliferation.
7. The scaffold according to claim 1 wherein said microrods are biodegradable.
8. The scaffold according to claim 1 wherein said microrods regulate cellular organization, structure, phenotype or function.
9. The scaffold according to claim 1 wherein said carrier is aqueous.
10. The scaffold according to claim 1 wherein said carrier is saline.
11. The scaffold according to claim 1 wherein said carrier is a buffer.
12. The scaffold according to claim 1 wherein said microrods are synthesized from one or more polymers.
13. The scaffold according to claim 1 wherein said microrods are synthesized from one or more copolymers.
14. The scaffold according to claim 12 wherein said polymer is selected from the group consisting of polylactic acid (PLA), polyglycolic acid (PGA), poly(ε-caprolactone) (PCL), poly(ethylene glycol) diacrylate (PEGDA), poly(ethylene glycol) dimethacrylate (PEGDMA), and SU-8.
15. The scaffold according to claim 13 wherein said copolymer is selected from the group consisting of poly(lactide-co-glycolide) (PLGA) and poly(DL-lactide-co-ε-caprolactone) (DLPLCL).
16. The scaffold according to claim 1 wherein said microrods are porous.
17. The scaffold according to claim 1 wherein said microrods have a shape of a regular polyhedron.
18. The scaffold according to claim 1 wherein said microrods have the shape of an irregular polyhedron.
19. The scaffold according to claim 1 wherein said microrods have a textured surface.
20. The scaffold according to claim 1 wherein said microrods are porous and have a textured surface.
21. The scaffold according to claim 1 wherein said microrods are associated with a biomolecule.
22. The scaffold according to claim 21 wherein said biomolecule is a an insulin-like growth factor (IGF) protein.
23. The scaffold according to claim 21 wherein said biomolecule is an E-domain peptide of an IGF protein.
24. The scaffold according to claim 21 wherein said biomolecule is an Ea, Eb, or Ec domain peptide of an IGF protein.
25. The scaffold according to claim 21 wherein said biomolecule is mechano-growth factor (MGF).
26. The scaffold according to claim 21 wherein said biomolecule is an E-domain peptide of mechano-growth factor (MGF).
27. The scaffold according to claim 26 wherein said MGF E-domain peptide is stabilized.
28. The scaffold according to claim 26 wherein said MGF E-domain peptide is native.
29. The scaffold according to claim 21 wherein said biomolecule is a biologically active fragment of mechano-growth factor (MGF).
30. The scaffold according to claim 21 wherein said biomolecule is elutable from the microrod.
31. The scaffold according to claim 1 wherein said microrods are associated with a targeting molecule that interacts with target cells expressing a binding partner for said targeting molecule.
32. The scaffold according to claim 1 which is an injectable composition.
33. The scaffold according to claim 1 which is surgically implantable.
34. The scaffold according to claim 1 wherein A is 15 μm, B is 15 μm, and L is 100 μm.
35. The scaffold according to claim 1 wherein the microrods have a stiffness ranging from 20 kPa to 100 kPa.